查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538256

診斷放射性同位素市場報告：2030 年趨勢、預測與競爭分析

Diagnostic Radioisotope Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

診斷放射性同位素的趨勢和預測

到 2030 年，全球診斷放射性同位素市場預計將達到 64 億美元，2024 年至 2030 年複合年成長率為 6.7%。該市場的主要促進因素是對疾病早期和準確診斷的需求不斷成長、診斷成像方式的不斷進步以及對α放射性同位素的需求不斷成長。全球診斷放射性同位素市場的未來前景廣闊，為醫院、專科診所、診斷中心以及學術和研究機構市場提供了機會。

診斷放射性同位素：按細分市場

該研究包括以放射性同位素、成像方式、應用、最終用途和地區對全球診斷放射性同位素的預測。

診斷放射性同位素市場洞察

Lucintel 預測，99mTechnetium預計在預測期內達到最高成長。

在這個市場中，專科診所預計在預測期內將出現最高成長。

在預測期內，北美仍將是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球診斷放射性同位素市場預計將達到 64 億美元。

Q2.市場成長預測是多少：

A2. 2024 年至 2030 年，全球診斷放射性同位素市場預計將以 6.7% 的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是對疾病早期和準確診斷的需求不斷成長、診斷成像方式的不斷進步以及對α放射性同位素的需求不斷成長。

Q4.市場的主要細分市場是：

A4. 診斷放射性同位素市場的未來對於醫院、專科診所、診斷中心以及學術和研究機構市場來說是充滿希望的。

Q5.市場的主要企業是：

A5. 主要診斷放射性同位素公司如下：

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測Technetium 99m 將在預測期內達到最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 預計北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球診斷放射性同位素市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球診斷放射性同位素市場趨勢（2018-2023）與預測（2024-2030）
  • 按放射性同位素分類的全球診斷放射性同位素市場
    • Technetium99m
    • 鉈201
    • 鎵67
    • 碘123
    • FDG
    • 銣82
    • 其他
  • 按成像方式分類的全球診斷放射性同位素市場
    • SPECT
    • PET
    • BETA放射體
  • 全球診斷放射性同位素市場（按應用）
    • 診斷
    • 治療
  • 按最終用途分類的全球診斷放射性同位素市場
    • 醫院
    • 專科診所
    • 診斷中心
    • 學術/研究機構
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球診斷放射性同位素市場（按地區）
  • 北美診斷放射性同位素市場
  • 歐洲診斷放射性同位素市場
  • 亞太地區診斷放射性同位素市場
  • 其他地區診斷放射性同位素市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球診斷放射性同位素市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球診斷放射性同位素市場的能力
    • 全球診斷放射性同位素市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes
簡介目錄

Diagnostic Radioisotope Trends and Forecast

The future of the global diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets. The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Diagnostic Radioisotope by Segment

The study includes a forecast for the global diagnostic radioisotope by radioisotope, imaging modality, application, end use, and region.

Diagnostic Radioisotope Market by Radioisotope [Shipment Analysis by Value from 2018 to 2030]:

  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others

Diagnostic Radioisotope Market by Imaging Modality [Shipment Analysis by Value from 2018 to 2030]:

  • SPECT
  • PET
  • Beta Emitters

Diagnostic Radioisotope Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic
  • Therapeutic

Diagnostic Radioisotope Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

Diagnostic Radioisotope Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Diagnostic Radioisotope Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies diagnostic radioisotope companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the diagnostic radioisotope companies profiled in this report include-

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes

Diagnostic Radioisotope Market Insights

Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.

Within this market, specialty clinic is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Diagnostic Radioisotope Market

Market Size Estimates: Diagnostic radioisotope market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Diagnostic radioisotope market size by various segments, such as by radioisotope, imaging modality, application, end use, and region in terms of value ($B).

Regional Analysis: Diagnostic radioisotope market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different radioisotopes, imaging modalities, applications, end uses, and regions for the diagnostic radioisotope market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the diagnostic radioisotope market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the diagnostic radioisotope market size?

Answer: The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030.

Q2. What is the growth forecast for diagnostic radioisotope market?

Answer: The global diagnostic radioisotope market is expected to grow with a CAGR of 6.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the diagnostic radioisotope market?

Answer: The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.

Q4. What are the major segments for diagnostic radioisotope market?

Answer: The future of the diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets.

Q5. Who are the key diagnostic radioisotope market companies?

Answer: Some of the key diagnostic radioisotope companies are as follows:

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes

Q6. Which diagnostic radioisotope market segment will be the largest in future?

Answer: Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.

Q7. In diagnostic radioisotope market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the diagnostic radioisotope market by radioisotope (technetium-99m, thallium-201, gallium-67, iodine-123, FDG, rubidium-82, and others), imaging modality (SPECT, PET, and beta emitters), application (diagnostic and therapeutic), end use (hospitals, specialty clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Diagnostic Radioisotope Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Diagnostic Radioisotope Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Diagnostic Radioisotope Market by Radioisotope
    • 3.3.1: Technetium-99m
    • 3.3.2: Thallium-201
    • 3.3.3: Gallium-67
    • 3.3.4: Iodine-123
    • 3.3.5: FDG
    • 3.3.6: Rubidium-82
    • 3.3.7: Others
  • 3.4: Global Diagnostic Radioisotope Market by Imaging Modality
    • 3.4.1: SPECT
    • 3.4.2: PET
    • 3.4.3: Beta Emitters
  • 3.5: Global Diagnostic Radioisotope Market by Application
    • 3.5.1: Diagnostic
    • 3.5.2: Therapeutic
  • 3.6: Global Diagnostic Radioisotope Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Specialty Clinics
    • 3.6.3: Diagnostic Centers
    • 3.6.4: Academic & Research Institutes
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Diagnostic Radioisotope Market by Region
  • 4.2: North American Diagnostic Radioisotope Market
    • 4.2.1: North American Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.2.2: North American Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
  • 4.3: European Diagnostic Radioisotope Market
    • 4.3.1: European Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.3.2: European Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
  • 4.4: APAC Diagnostic Radioisotope Market
    • 4.4.1: APAC Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.4.2: APAC Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
  • 4.5: ROW Diagnostic Radioisotope Market
    • 4.5.1: ROW Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.5.2: ROW Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Diagnostic Radioisotope Market by Radioisotope
    • 6.1.2: Growth Opportunities for the Global Diagnostic Radioisotope Market by Imaging Modality
    • 6.1.3: Growth Opportunities for the Global Diagnostic Radioisotope Market by Application
    • 6.1.4: Growth Opportunities for the Global Diagnostic Radioisotope Market by End Use
    • 6.1.5: Growth Opportunities for the Global Diagnostic Radioisotope Market by Region
  • 6.2: Emerging Trends in the Global Diagnostic Radioisotope Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Diagnostic Radioisotope Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Radioisotope Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Siemens Healthineers
  • 7.3: Koninklijke Philips
  • 7.4: Cardinal Health
  • 7.5: Lantheus Holdings
  • 7.6: Bayer
  • 7.7: Bracco
  • 7.8: Eckert & Ziegler
  • 7.9: Nordion
  • 7.10: NTP Radioisotopes